EP3702471C0
Modified polymerases for improved incorporation of nucleotide analogues
Abstract
This record has no abstract on file.
Term
8.8 yearsto projected expiry
Projected expiry 25 June 2035, counted from filing; an application has no term until it is granted.
- Priority and filed
- Published
- Today
- Projected expiry
28 members in 12 offices
Members28
| Document | Office | Kind | |
|---|---|---|---|
| CA2951416A1 | Canada | A1 | |
| WO2015200693A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2015376582A1 | United States of America | A1 | |
| AU2015279794A1 | Australia | A1 | |
| CN106536728A | China | A | |
| EP3161154A1 | European Patent Office (EPO) | A1 | |
| JP2017518750A | Japan | A | |
| US9765309B2 | United States of America | B2 | |
| US2017355970A1 | United States of America | A1 | |
| HK1231517A | Hong Kong, China | A | |
| HK1231517A1 | Hong Kong, China | A1 | |
| EP3161154B1 | European Patent Office (EPO) | B1 | |
| PT3161154T | Portugal | T | |
| DK3161154T3 | Denmark | T3 | |
| JP6737710B2 | Japan | B2 | |
| JP2020127415A | Japan | A | |
| EP3702471A1 | European Patent Office (EPO) | A1 | |
| PL3161154T3 | Poland | T3 | |
| ES2788949T3 | Spain | T3 | |
| US10870836B2 | United States of America | B2 | |
| US2021246435A1 | United States of America | A1 | |
| AU2015279794B2 | Australia | B2 | |
| AU2021290289A1 | Australia | A1 | |
| JP2022033882A | Japan | A | |
| AU2021290289B2 | Australia | B2 | |
| US12110514B2 | United States of America | B2 | |
| EP3702471B1 | European Patent Office (EPO) | B1 | |
| EP3702471C0This record | European Patent Office (EPO) | C0 |
34 legal events, as 6 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Renewal fee for the european patent with unitary effect paidU20 | U20 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Definitive protectionFG2A | FG2A | ES | |
| Unitary effect registeredU07 | U07 | EP | |
| Request for unitary effect filedU01 | U01 | EP | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| Ip right grantedGrantedST27 STATUS EVENT CODE: U-0-0-F10-F00 (AS PROVIDED BY THE NATIONAL OFFICE)F10 | F10 | CH | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE PATENT HAS BEEN GRANTEDSTAA | STAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: GRANT OF PATENT IS INTENDEDSTAA | STAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: EXAMINATION IS IN PROGRESSSTAA | STAA | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting states (corrected)RBV | RBV | EP | |
| Requests to designate patent in hong kongDE | DE | HK | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: REQUEST FOR EXAMINATION WAS MADESTAA | STAA | EP | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION HAS BEEN PUBLISHEDSTAA | STAA | EP |
Numbers
- Publication
- 3702471
- Application
- 8427
Titles3
- German
- MODIFIZIERTE POLYMERASEN ZUR VERBESSERTEN INKORPORATION VON NUKLEOTIDANALOGA
- English
- MODIFIED POLYMERASES FOR IMPROVED INCORPORATION OF NUCLEOTIDE ANALOGUES
- French
- POLYMÉRASES MODIFIÉES POUR L'INCORPORATION AMÉLIORÉE D'ANALOGUES NUCLÉOTIDIQUES
Classification
- CPC, 2
- C12N9/1252
- C12Y207/07007
- IPC, 2
- C12Q1 68
- C12N9 12
Designated states38
- Contracting states, 38
- Albania
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Croatia
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Lithuania
- Luxembourg
- Latvia
and 14 moreShow fewer
- Monaco
- North Macedonia
- Malta
- Netherlands (Kingdom of the)
- Norway
- Poland
- Portugal
- Romania
- Serbia
- Sweden
- Slovenia
- Slovakia
- San Marino
- Türkiye